Immunology: Current Research
Open Access

Understanding the Molecular Pathways of Inflammation in Chronic Diseases and Therapeutic Targets

Received Date: Jan 01, 2025 / Accepted Date: Jan 31, 2025 / Published Date: Jan 31, 2025

Citation: Takeshi Y (2025) Understanding the Molecular Pathways of Inflammationin Chronic Diseases and Therapeutic Targets. Immunol Curr Res, 9: 245.DOI: 10.4172/icr.1000245

Copyright: © 2025 Takeshi Y. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

To read the full article Peer-reviewed Article PDF

Chronic inflammation is a central feature in the pathogenesis of numerous diseases, including cardiovascular
diseases, diabetes, cancer, and neurodegenerative disorders. Understanding the molecular pathways that drive
chronic inflammation is critical for identifying therapeutic targets and developing effective treatments. The inflammatory
response is primarily regulated by key signaling pathways, such as the NF-κB, JAK-STAT, and inflammasome
pathways. Dysregulation of these pathways leads to prolonged and excessive inflammation, which contributes to
tissue damage and disease progression. Recent advancements in molecular biology have identified Janel targets for
intervention, including cytokine inhibitors, immune checkpoint modulators, and small molecule inhibitors that regulate
these inflammatory pathways. Therapeutic approaches targeting these pathways have shown promise in preclinical
and clinical studies. This review discusses the molecular mechanisms of inflammation in chronic diseases, explores
current therapeutic strategies, and highlights emerging targets for future treatments. Understanding these pathways
will pave the way for the development of targeted therapies to alleviate chronic inflammation and improve patient
outcomes.

Keywords